Empirical Financial Services LLC d.b.a. Empirical Wealth Management purchased a new stake in Phibro Animal Health Corporation (NASDAQ:PAHC - Free Report) during the 1st quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor purchased 10,486 shares of the company's stock, valued at approximately $224,000.
Several other institutional investors and hedge funds also recently modified their holdings of PAHC. Point72 Asia Singapore Pte. Ltd. purchased a new stake in shares of Phibro Animal Health in the fourth quarter valued at about $29,000. Lazard Asset Management LLC lifted its holdings in shares of Phibro Animal Health by 2,739.7% in the fourth quarter. Lazard Asset Management LLC now owns 1,647 shares of the company's stock valued at $34,000 after purchasing an additional 1,589 shares in the last quarter. Aquatic Capital Management LLC purchased a new stake in shares of Phibro Animal Health in the fourth quarter valued at about $69,000. Virtus Fund Advisers LLC purchased a new stake in shares of Phibro Animal Health in the fourth quarter valued at about $69,000. Finally, Curat Global LLC purchased a new stake in shares of Phibro Animal Health in the first quarter valued at about $146,000. Hedge funds and other institutional investors own 99.34% of the company's stock.
Phibro Animal Health Stock Performance
NASDAQ:PAHC opened at $26.11 on Monday. The company has a quick ratio of 1.23, a current ratio of 2.91 and a debt-to-equity ratio of 2.67. The company has a market cap of $1.06 billion, a P/E ratio of 33.47, a P/E/G ratio of 0.44 and a beta of 0.80. Phibro Animal Health Corporation has a fifty-two week low of $16.16 and a fifty-two week high of $31.80. The firm's 50 day moving average is $26.70 and its two-hundred day moving average is $23.32.
Phibro Animal Health (NASDAQ:PAHC - Get Free Report) last posted its quarterly earnings results on Wednesday, May 7th. The company reported $0.63 earnings per share for the quarter, topping analysts' consensus estimates of $0.52 by $0.11. The company had revenue of $347.80 million for the quarter, compared to the consensus estimate of $352.41 million. Phibro Animal Health had a net margin of 2.68% and a return on equity of 30.51%. Analysts expect that Phibro Animal Health Corporation will post 1.95 EPS for the current year.
Phibro Animal Health Announces Dividend
The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, September 24th. Stockholders of record on Wednesday, September 3rd will be given a $0.12 dividend. The ex-dividend date of this dividend is Wednesday, September 3rd. This represents a $0.48 annualized dividend and a dividend yield of 1.8%. Phibro Animal Health's dividend payout ratio is presently 61.54%.
Wall Street Analysts Forecast Growth
Several equities analysts recently issued reports on the stock. BNP Paribas Exane raised shares of Phibro Animal Health from an "underperform" rating to a "neutral" rating and set a $24.00 price objective on the stock in a research note on Monday, June 16th. Morgan Stanley set a $26.00 price objective on shares of Phibro Animal Health and gave the company an "equal weight" rating in a research note on Wednesday, June 25th. JPMorgan Chase & Co. raised shares of Phibro Animal Health from a "neutral" rating to an "overweight" rating and upped their price objective for the company from $25.00 to $35.00 in a research note on Monday, July 7th. BNP Paribas raised shares of Phibro Animal Health to a "hold" rating in a research note on Monday, June 16th. Finally, Wall Street Zen raised shares of Phibro Animal Health from a "hold" rating to a "buy" rating in a research note on Friday, May 9th. Two research analysts have rated the stock with a sell rating, three have assigned a hold rating and two have given a buy rating to the company. According to MarketBeat.com, the company presently has an average rating of "Hold" and an average target price of $24.40.
Check Out Our Latest Analysis on Phibro Animal Health
Phibro Animal Health Profile
(
Free Report)
Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.
Further Reading
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Phibro Animal Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Phibro Animal Health wasn't on the list.
While Phibro Animal Health currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
